Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics

Molecular biomarkers in blood are needed to aid the early diagnosis and clinical assessment of glioblastoma (GBM). Here, in order to identify biomarker candidates in plasma of GBM patients, we performed quantitative comparisons of the plasma proteomes of GBM patients (n = 14) and healthy controls (n...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:PLoS One
Prif Awduron: Miyauchi, Eisuke, Furuta, Takuya, Ohtsuki, Sumio, Tachikawa, Masanori, Uchida, Yasuo, Sabit, Hemragul, Obuchi, Wataru, Baba, Tomoko, Watanabe, Michitoshi, Terasaki, Tetsuya, Nakada, Mitsutoshi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Public Library of Science 2018
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841790/
https://ncbi.nlm.nih.gov/pubmed/29513714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0193799
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg